Literature DB >> 27198546

Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care.

Katrin Weigmann1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27198546      PMCID: PMC4931570          DOI: 10.15252/embr.201642616

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  8 in total

Review 1.  ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Authors:  Linda Härmark; Florence van Hunsel; Birgitta Grundmark
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

Review 2.  Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Authors:  A J Avery; C Anderson; C M Bond; H Fortnum; A Gifford; P C Hannaford; L Hazell; J Krska; A J Lee; D J McLernon; E Murphy; S Shakir; M C Watson
Journal:  Health Technol Assess       Date:  2011-05       Impact factor: 4.014

3.  How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.

Authors:  Lorna Hazell; Victoria Cornelius; Philip Hannaford; Saad Shakir; Anthony J Avery
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

4.  Adverse drug reaction reporting by patients: an overview of fifty countries.

Authors:  Florence Margraff; Delphine Bertram
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

5.  Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

Authors:  Beatrice A Golomb; John J McGraw; Marcella A Evans; Joel E Dimsdale
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

Authors:  Florence van Hunsel; Anneke Passier; Kees van Grootheest
Journal:  Br J Clin Pharmacol       Date:  2009-02-26       Impact factor: 4.335

7.  What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse; Anders Carlsten
Journal:  BMC Clin Pharmacol       Date:  2011-10-25

8.  Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse; Anders Carlsten
Journal:  BMC Pharmacol Toxicol       Date:  2012-12-23       Impact factor: 2.483

  8 in total
  4 in total

1.  Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.

Authors:  George Tsey Sabblah; Delese Mimi Darko; Hudu Mogtari; Linda Härmark; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

2.  The Role of European Patient Organizations in Pharmacovigilance.

Authors:  Cristiano Matos; Gerda Weits; Florence van Hunsel
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

3.  Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study.

Authors:  Åsa Mellgren; Lars E Eriksson; Maria Reinius; Gaetano Marrone; Veronica Svedhem
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

4.  Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database.

Authors:  Tadashi Toki; Shunsuke Ono
Journal:  Drugs Real World Outcomes       Date:  2018-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.